GlassScriptPhysician profile
Winston E Barzell
NPI 1114919511
$1,817.16
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $463 · 2021: $19.06 · 2022: $282 · 2023: $279 · 2024: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $370.03 | 2020 | |
| Janssen Biotech, INC. | $173.29 | 2019-2022 | |
| Astellas Pharma US INC | $170.82 | 2019-2020 | |
| Abbvie INC. | $130.90 | 2019-2024 | Botox |
| Boston Scientific Corporation | $126.47 | 2020-2023 | Spaceoar Vue System - 10ml, Spectra |
| Pfizer INC. | $107.95 | 2019-2024 | |
| Allergan, INC. | $90.39 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $82.08 | 2023 | Gemtesa, Orgovyx |
| 180 Medical, INC. | $68.53 | 2019-2023 | Magic3 Intermittent Catheter |
| Tolmar, INC. | $48.92 | 2024 | |
| Ferring Pharmaceuticals INC. | $47.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $47.72 | 2022-2024 | |
| C. R. Bard, INC. & Subsidiaries | $44.18 | 2022 | |
| Antares Pharma, INC. | $39.54 | 2019 | |
| Endo Pharmaceuticals INC. | $33.08 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $30.47 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $30.33 | 2019 | |
| Palette Life Sciences, INC. | $28.52 | 2022 | |
| Axonics, INC. | $23.47 | 2024 | Axonics |
| Bioprotect Medical, INC. | $23.36 | 2024 | Bioprotect Balloon Implant System |
| Teleflex LLC | $19.62 | 2023 | Urolift |
| Coloplast Corp | $19.39 | 2024 | |
| Myovant Sciences INC. | $16.10 | 2022 | |
| Medtronic, INC. | $16.07 | 2023 | Interstim |
| Urogen Pharma, INC. | $15.00 | 2023 | Jelmyto |
| Aytu Biopharma, INC. | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Barzell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.